[1] Guo Jian Li Zhengqing,.30 Cases of Acute Inferior Myocardial Infarction Treated by Shenmai Injection and Western Medicine [J]. Modern Traditional Chinese Medicine, 2019, (01): 45-47,50. [doi: 10.13424/j.cnki.mtcm.2019.01.016]
30 Cases of Acute Inferior Myocardial Infarction Treated by Shenmai Injection and Western Medicine
- Article number:
- 1672-0571(2019)01-0045-04
- ZTFLH:
- R256.2
- Code:
- A
- Abstract:
- To investigate the curative effect of Shenmai Injection on acute inferior myocardial infarction. Method: Fifty - nine patients with acute inferior myocardial infarction in Shenmu Hospital were randomly divided into treatment group ( n = 30) and control group ( n = 29) . The patients in the control group were given emergency interventional therapy immediately after admission, and routine antiplatelet, anticoagulant and lipid - lowering drugs. The patients in the treatment group were given intravenous drip of Shenmai Injection on the basis of the control group. Blood pressure, heart rate, cardiac function, hospitalization time, brain natriuretic peptide and changes of high - sensitivity C – reactive protein levels were observed in the two groups. Result: During hospitalization, the effective rate of patients in the treatment group ( 93. 33%) was significantly higher than that in the control group ( 72.41%) , with statistical significance ( P < 0. 05) ; the incidence of heart failure in the treatment group ( 6. 67%) was significantly lower than that in the symptomatic group ( 17. 24%) , with statistical significance ( P <0. 05) ; the length of stay in the treatment group was significantly lower than that in the symptomatic group ( P <0. 05) ; The levels of - proBNP and hs - CPR in the control group were significantly higher than those in the control group, the difference is statistically significant ( P < 0. 05) .There were no adverse reactions in both groups. Conclusion: On the basis of routine drug treatment,Shenmai Injection can significantly improve the therapeutic effect of acute inferior myocardial infarction.
References:
[1]邵占东,孙学枝,梁建成. 急性下壁心肌梗死临床并发症及特点分析 [ J]. 宁夏医学杂志,2016,38 (8):715- 716.
[2]杨晓云. 急性下壁心肌梗死的房室传导阻滞及其罪犯血管[J]. 实用心电学杂志,2016,25(4):275 - 277.
[3]曹庆艳,宗文仓,王桂平,等. 快速扩容对急性下壁心肌梗死血管再通后所致低血压疗效观察[ J]. 中国医药导刊, 2017,19(5):438 - 439.
[4]王晓明,陈念,石红玲. 冠状动脉解剖?供血特点与常见冠状动脉病变及其心电图特征[ J]. 心电图杂志( 电子版),2014,3(3):182 - 186.
[5]贺海军. 参脉注射液治疗病毒性心肌炎的临床效果[J]. 世界最新医学信息文摘,2016,16(23):148 + 150.
[6]中华医学会心血管病学分会?中华心血管病杂志编辑委员会. 急性 ST 段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志. 2015, 43(5): 0253 - 3758.
[7]Kim AL, Kwon JC, Park I, et al. Reference equations forthe six - minute walk distance in healthy Korean adults,aged 22 - 59 years[J]. Tuberc Respir Dis, 2014, 76(6):269 - 275.
[8] Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker,etal. 2016 ESCguidelines for the diagnosis and treatment ofacute and chronic heart failure [ J]. European Journal ofHeart Failure,2016,18(8),891 - 975.
[9]刘香君. 右冠与左回旋支引起急性下壁心肌梗死临床观察[D]. 天津:天津医科大学,2016
[10]王振东,李宝红. 参麦注射液联合美托洛尔治疗慢性心力衰竭 32 例[J]. 现代中医药,2009,29(6):11 - 12.
[11]卢强,李联社. 参麦注射液合用咪达普利治疗扩张型心肌 病 疗 效 观 察 [ J]. 现 代 中 医 药,2010,30 (1):11- 12.
[12]张义轩, 张挚, 杨晴,等. 体外循环下经主动脉根部注射参麦注射液对二尖瓣置换术患者心肌损伤的影响[J]. 中华实验外科杂志,2014,31(7):1594 - 1596
[13]刘焯华. 参麦注射液联合尿激酶治疗急性下壁心肌梗死的疗效及对心功能的影响[J]. 医药论坛杂志,2017,38(5):160 - 162.
[14]杜军,郭慧敏,黄路非,等. 基于大数据的某院例均费用与住院天数关系研究[J]. 中国病案,2017,18(2):51- 54.
Memo
收稿日期：２０１８－０１－２０ 编辑：杨芳艳